Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabrielle Fredman

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Nature Immunology|October 3, 2006
Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expressionAmiram Ariel, Gabrielle Fredman, Yee-Ping Sun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 18, 2012
Resolvin E1 and chemokine-like receptor 1 mediate bone preservationLi Gao, Dan Faibish, Gabrielle Fredman, et al.
Science Translational Medicine|February 20, 2015
Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic miceGabrielle Fredman, Nazila Kamaly, Stefano Spolitu, et al.
The Journal of Biological Chemistry|October 12, 2005
The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clusteringAmiram Ariel, Pin-Lan Li, Wei Wang, et al.
Vascular Pharmacology|August 4, 2025
Resolvin D2 limits senescent cell accumulation in atherosclerotic plaquesMasharh Lipscomb, Ignacia Salfate Del Rio, Maya Eid, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2020
Resolvin D1 promotes efferocytosis in aging by limiting senescent cell-induced MerTK cleavageNicholas Rymut, Justin Heinz, Sudeshna Sadhu, et al.
Blood|May 16, 2008
Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and plateletsMaria Dona, Gabrielle Fredman, Jan M Schwab, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2013
Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticlesNazila Kamaly, Gabrielle Fredman, Manikandan Subramanian, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2016
MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammationBishuang Cai, Edward B Thorp, Amanda C Doran, et al.
Frontiers in Cardiovascular Medicine|August 8, 2025
Editorial: New trends in vascular biology 2024Sarvesh Chelvanambi, Hong Chen, Margreet R De Vries, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Nature Immunology|October 3, 2006
Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expressionAmiram Ariel, Gabrielle Fredman, Yee-Ping Sun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 18, 2012
Resolvin E1 and chemokine-like receptor 1 mediate bone preservationLi Gao, Dan Faibish, Gabrielle Fredman, et al.
Science Translational Medicine|February 20, 2015
Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic miceGabrielle Fredman, Nazila Kamaly, Stefano Spolitu, et al.
The Journal of Biological Chemistry|October 12, 2005
The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clusteringAmiram Ariel, Pin-Lan Li, Wei Wang, et al.
Vascular Pharmacology|August 4, 2025
Resolvin D2 limits senescent cell accumulation in atherosclerotic plaquesMasharh Lipscomb, Ignacia Salfate Del Rio, Maya Eid, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2020
Resolvin D1 promotes efferocytosis in aging by limiting senescent cell-induced MerTK cleavageNicholas Rymut, Justin Heinz, Sudeshna Sadhu, et al.
Blood|May 16, 2008
Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and plateletsMaria Dona, Gabrielle Fredman, Jan M Schwab, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2013
Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticlesNazila Kamaly, Gabrielle Fredman, Manikandan Subramanian, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2016
MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammationBishuang Cai, Edward B Thorp, Amanda C Doran, et al.
Frontiers in Cardiovascular Medicine|August 8, 2025
Editorial: New trends in vascular biology 2024Sarvesh Chelvanambi, Hong Chen, Margreet R De Vries, et al.
Pageof 7